David Vikström

Member of the company's administrative, management or supervisory body

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Sep 29, 2017 – Sep 8, 2023

David Vikström reported 21 transactions between Sep 29, 2017 and Sep 8, 2023. The buy and sell totals below count only codes SACQ, SDIS.

Open-market buys (SACQ)
696.2K SEK
12 purchases on file priced rows only
Open-market sales (SDIS)
560.6K SEK
2 sales on file priced rows only
All reported transactions
21
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought Xbrane Biopharma AB shares worth 674,204 SEK between Aug 9, 2022 and Aug 19, 2022

Cluster buying

3 different insiders made 9 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Xbrane Biopharma AB shares worth 674,204 SEK between Aug 9, 2022 and Aug 19, 2022
Date Insider Transaction Shares Price Value Filing
Aug 9, 2022 Anette Lindqvist SACQ Acquisition 2,000 86.00 SEK 172,000 SEK FI filing ↗
Aug 16, 2022 Maria Edebrink SACQ Acquisition 118 84.90 SEK 10,018 SEK FI filing ↗
Aug 17, 2022 Maria Edebrink SACQ Acquisition 1,000 87.10 SEK 87,100 SEK FI filing ↗
Aug 17, 2022 Maria Edebrink SACQ Acquisition 1,000 86.90 SEK 86,900 SEK FI filing ↗
Aug 17, 2022 Maria Edebrink SACQ Acquisition 500 86.80 SEK 43,400 SEK FI filing ↗
Aug 17, 2022 Maria Edebrink SACQ Acquisition 500 86.69 SEK 43,346 SEK FI filing ↗
Aug 17, 2022 Maria Edebrink SACQ Acquisition 742 86.95 SEK 64,515 SEK FI filing ↗
Aug 18, 2022 David Vikström SACQ Acquisition 1,500 84.00 SEK 126,000 SEK FI filing ↗
Aug 19, 2022 David Vikström SACQ Acquisition 500 81.85 SEK 40,925 SEK FI filing ↗

Total of the rows above: 674,204 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

5 insiders bought Xbrane Biopharma AB shares worth 324,581 SEK between May 28, 2020 and Jun 26, 2020

Cluster buying

5 different insiders made 6 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

5 insiders bought Xbrane Biopharma AB shares worth 324,581 SEK between May 28, 2020 and Jun 26, 2020
Date Insider Transaction Shares Price Value Filing
May 28, 2020 Maria Edebrink SACQ Acquisition 200 47.00 SEK 9,400 SEK FI filing ↗
May 28, 2020 Maria Edebrink SACQ Acquisition 1,300 47.75 SEK 62,079 SEK FI filing ↗
May 29, 2020 Siavash Bashiri SACQ Acquisition 5,320 47.37 SEK 252,001 SEK FI filing ↗
Jun 22, 2020 Karl Martin Erik Åmark SACQ Acquisition 1,750 0.22 SEK 392 SEK FI filing ↗
Jun 26, 2020 David Vikström SACQ Acquisition 463 0.22 SEK 104 SEK FI filing ↗
Jun 26, 2020 Susanna Helgesen SACQ Acquisition 2,700 0.22 SEK 605 SEK FI filing ↗

Total of the rows above: 324,581 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

4 insiders bought Xbrane Biopharma AB shares worth 226,991 SEK between Jan 14, 2019 and Jan 17, 2019

Cluster buying

4 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

4 insiders bought Xbrane Biopharma AB shares worth 226,991 SEK between Jan 14, 2019 and Jan 17, 2019
Date Insider Transaction Shares Price Value Filing
Jan 14, 2019 David Vikström SACQ Acquisition 1,735 46.85 SEK 81,285 SEK FI filing ↗
Jan 14, 2019 Siavash Bashiri SACQ Acquisition 2,200 46.48 SEK 102,256 SEK FI filing ↗
Jan 15, 2019 Susanna Helgesen SACQ Acquisition 233 47.00 SEK 10,951 SEK FI filing ↗
Jan 16, 2019 Susanna Helgesen SACQ Acquisition 267 47.00 SEK 12,549 SEK FI filing ↗
Jan 17, 2019 Dina Jurman SACQ Acquisition 420 47.50 SEK 19,950 SEK FI filing ↗

Total of the rows above: 226,991 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 21 most recent rows are grouped into 21 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Xbrane Biopharma AB SDIS Disposal 12,518 shares 407.5K SEK at 32.55 SEK FI filing ↗
  2. Xbrane Biopharma AB SDIS Disposal 4,647 shares 153.1K SEK at 32.95 SEK FI filing ↗
  3. Xbrane Biopharma AB SEXI Exercise increasenot a buy/sell decision 3,000 shares 673 SEK at 0.22 SEK FI filing ↗
  4. Xbrane Biopharma AB SEXD Exercise decreasenot a buy/sell decisionreported at zero 3,000 shares 0 SEK at 0.00 SEK FI filing ↗
  5. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decisionreported at zero 3,000 shares 0 SEK at 0.00 SEK FI filing ↗
  6. Xbrane Biopharma AB SACQ Acquisition 500 shares 40.9K SEK at 81.85 SEK FI filing ↗
  7. Xbrane Biopharma AB SACQ Acquisition 1,500 shares 126.0K SEK at 84.00 SEK FI filing ↗
  8. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 10,165 shares 699.4K SEK at 68.80 SEK FI filing ↗
  9. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 1,135 shares 190.2K SEK at 167.60 SEK FI filing ↗
  10. Xbrane Biopharma AB SACQ Acquisition 1,500 shares 103.1K SEK at 68.70 SEK FI filing ↗
  11. Xbrane Biopharma AB SACQ Acquisition 463 shares 104 SEK at 0.22 SEK FI filing ↗
  12. Xbrane Biopharma AB SACQ Acquisitionreported at zero 463 shares 0 SEK at 0.00 SEK FI filing ↗
  13. Xbrane Biopharma AB SACQ Acquisition 580 shares 19.4K SEK at 33.50 SEK FI filing ↗
  14. Xbrane Biopharma AB SACQ Acquisition 1,482 shares 49.6K SEK at 33.50 SEK FI filing ↗
  15. Xbrane Biopharma AB SACQ Acquisition 3,160 shares 94.8K SEK at 30.00 SEK FI filing ↗
  16. Xbrane Biopharma AB SSUB Subscriptionnot a buy/sell decision 1,333 shares 40.0K SEK at 30.00 SEK FI filing ↗
  17. Xbrane Biopharma AB SACQ Acquisition 1,735 shares 81.3K SEK at 46.85 SEK FI filing ↗
  18. Xbrane Biopharma AB SACQ Acquisition 765 shares 51.2K SEK at 66.94 SEK FI filing ↗
  19. Xbrane Biopharma AB SACQ Acquisition 24,000 shares 100.3K SEK at 4.18 SEK FI filing ↗
  20. Xbrane Biopharma AB SACQ Acquisition 370 shares 29.5K SEK at 79.66 SEK FI filing ↗
  21. Xbrane Biopharma AB SALL Allotmentnot a buy/sell decision 2,500 shares 600 SEK at 0.24 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Xbrane Biopharma AB SE0007789409 Xbrane Biopharma AB 6,468 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where David Vikström reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.